Maria Wang
- Ophthalmology top 1%
- Retinal Diseases and Treatments 4
- Hematology top 2%
- Multiple Myeloma Research and Treatments 19
- Hemophilia Treatment and Research 5
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 4
- Oncology top 10%
- Peptidase Inhibition and Analysis 6
-
- Protein Degradation and Inhibitors 19
- Ubiquitin and proteasome pathways 5
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Michael LarsenPascal W. HaslerChristian PrünteInger Christine MunchYan RenBirgit SanderRajesh ChopraSuzana S. Couto
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Maria Wang
41 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Ophthalmology 621
- Hematology 604
- Internal Medicine 147
- Radiology, Nuclear Medicine and Imaging 397
- Oncology 362
Countries citing papers authored by Maria Wang
This map shows the geographic impact of Maria Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Wang more than expected).
Fields of papers citing papers by Maria Wang
This network shows the impact of papers produced by Maria Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Wang. The network helps show where Maria Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maria Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2021 | 15 | |
| 4 | 2020 | 11 | |
| 5 | 2019 | 22 | |
| 6 | 2019 | 38 | |
| 7 | 2019 | 144 | |
| 8 | 2017 | 1 | |
| 9 | 2015 | 13 | |
| 10 | 2015 | 91 | |
| 11 | 2014 | 37 | |
| 12 | Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogsbreakdown → | 2014 | 371 |
| 13 | 2013 | 71 | |
| 14 | Reduction in Initial Length of Stay with Rivaroxaban Single-Drug Regimen versus LMWH-VKA Standard of Care | 2012 | 3 |
| 15 | High-Tension Median Cable In-Service Performance Evaluation and Cost-Effectiveness Analysis | 2010 | 2 |
| 16 | Central serous chorioretinopathybreakdown → | 2007 | 527 |
| 17 | 2005 | 65 | |
| 18 | 2005 | 39 | |
| 19 | 2001 | 16 | |
| 20 | 1999 | 22 |
About Maria Wang
Maria Wang is a scholar working on Hematology, Internal Medicine, Ophthalmology, Genetics and Oncology, having authored 42 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (19 papers), Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (5 papers), Hemophilia Treatment and Research (5 papers), Retinal Diseases and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). The work is most often cited by research in Ophthalmology (621 citations), Hematology (604 citations), Internal Medicine (147 citations), Radiology, Nuclear Medicine and Imaging (397 citations) and Oncology (362 citations). Maria Wang has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Michael Larsen, Pascal W. Hasler, Christian Prünte, Inger Christine Munch, Yan Ren, Birgit Sander, Rajesh Chopra, Suzana S. Couto, Peter Schäfer and Anjan Thakurta. Their work appears in journals such as Blood, Haemophilia, British Journal of Haematology, Energy Economics and Acta Ophthalmologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.